Determination of melamine cytotoxicity

• Autorzy: Radko L , Minta M. , Stypula-Trebas S. , Zmudzki J.
• Języki publikacji: EN

Abstrakty

EN

Cytotoxic potential of melamine was evaluated with the use of two in vitro models i.e. cell cultures of rat hepatoma (line FaO) and rat skeletal muscle (line L6). The cultures were exposed for 24, 48, and 72 h to melamine at eight concentrations, ranged from 0.01 to 10 mM. Four different assays were applied in which various biochemical endpoints were assessed: mitochondrial activity - MTT reduction assay, proliferation - Commassie Brilliant Blue (CBB) dye binding assay, lysosomal activity - neutral red uptake (NRU) assay, and membrane integrity - LDH release assay. Effective concentrations (EC₂₀, EC₅₀, EC₈₀) were calculated from concentration-response curves, and then they were averaged over three independently conducted experiments. It was found that MTT assay was the most sensitive to this compound. After 48 h exposure EC₅₀ values (mM, mean ± SD) for FaO and L6 cells were 6.4 ± 0.62, and 8.2 ± 1.51, respectively. The inhibition of lysosomal activity measured by NRU assay, and damage of plasma membrane measured by LDH assay were detected in L6 (but not in FaO) cells; however, the effects took place after longer (72 h) exposure. At that time EC₅₀ values were 5.2 mM and 9.2 mM for NRU and LDH, respectively. In spite of the low cytotoxicity of melamine, more studies are needed for hazard identification and characterization of the compound.

Słowa kluczowe

PL

melamine; cytotoxicity; determination; cell culture; rat hepatoma; skeletal muscle; in vitro method

• Wydawca: -
• Czasopismo: Bulletin of the Veterinary Institute in Puławy
• Rocznik: 2010
• Tom: 54
• Numer: 2
• Opis fizyczny: p.223-228,fig.,ref.

Twórcy

autor

Radko L

• National Veterinary Research Institute, 24-100 Pulawy, Poland

autor

Minta M.

autor

Stypula-Trebas S.

autor

Zmudzki J.

Bibliografia

• 1. Amacher D.E.: Drug - associated mitochondrial toxicity and its detection. Curr Med Chem 2005, 12, 1829-1839.
• 2. Berridge M.V., Herst P.M., Tan A.S.: Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev 2005, 11, 127-152.
• 3. Borenfreund E., Puerner J.A.: Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 1985, 24, 119-124.
• 4. Bradford M.M.: A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of dye binding. Anal Biochem 1976, 72, 248- 254.
• 5. Brown C.A., Brown S.A.: Food and pharmaceuticals: lessons learned from global contaminations with melamine/cyanuric acid and diethylene glycol. Vet Pathol Online 2010, 47, 45-52.
• 6. Chan E.Y., Griffiths S.M., Chan C.W.: Public-health risks of melamine in milk products. Lancet 2008, 372, 1444- 1445.
• 7. Chen H.T., Neerman M.F., Parrish A.R., Simanek E.E.: Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery. J Am Chem Soc 2004, 126, 10044-10048.
• 8. Cremonezzi D.C., Diaz M.P., Valentich M.A., Eynard A.R.: Neoplastic and preneoplastic lesions induced by melamine in rat urothelium are modulated by dietary polyunsaturated fatty acids. Food Chem Toxicol 2004, 42, 1999-2007.
• 9. Dobson R.L.M., Motlagh S., Quijano M., Cambron R.T., Baker T.R., Pullen A.M., Regg B.T., Bigalow-Kern A.S., Vennard T., Fix A., Reimschuessel R., Overmann G., Shan Y., Daston G.P.: Identification and characterization of toxicity of contaminants in pet food leading to an outbreak of renal toxicity in cats and dogs. Toxicol Sci 2008, 106, 251-262.
• 10. Eisenbrand G., Pool-Zobel B., Baker V., Balls M., Blaauboer B. J., Boobis A., Carere A., Kevekordes S., Lhuguenot J. C., Pieters R., Kleiner J.: Methods of in vitro toxicology. Food Chem Toxicol 2002, 40, 193-236.
• 11. Fernández Freire P., Peropadre A., Pėrez Martin J.M., Herrero O., Hazen M.J.: An integrated cellular model to evaluate cytotoxic effects in mammalian cell lines. Toxicol in Vitro 2009, 23, 1553-1558.
• 12. Flint O.P.: Toxicity at the cellular level. In: Animal Alternatives, Welfare and Ethics. Edited by L.F.M. van Zutphen and M. Balls. Elsevier Science B.V., Amsterdam, 1997, pp. 523-529.
• 13. Fotakis G., Timbrell J.A.: In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol Lett 2006, 160, 171-177.
• 14. Gossner C. M.-E., Schlundt J., Embarek P.B., Hird S., Lo-Fo-Wong D., Beltran J.J.O., Teoh K.N., Tritscher A.: The melamine incident: implications for international food and feed safety. Environ Health Perspect 2009, 117, 1803-1808.
• 15. Guan N., Fan Q., Ding J., Zhao Y., Lu J., Ai Y., Xu G., Zhu S., Yao C., Jiang L., Miao J., Zhang H., Zhao D., Liu X., Yao Y.: Melamine contaminated powdered formula and urolithiasis in young children. N Engl J Med 2009, 360, 1067-1074.
• 16. Hau A.K., Kwan T.H., Li P.J.: Melamine toxicity and the kidney. J Am Soc Nephrol 2009, 20, 245-250.
• 17. Holst C.M., Oredsson S.M.: Comparison of three cytotoxicity tests in the evaluation of the cytotoxicity of spermine analogue on human breast cancer cell lines. Toxicol In Vitro 2005, 19, 379-387.
• 18. Korzeniewski C., Calleawert D.M.: An enzyme-release assay for natura cytotoxicity. J Immunol Methods 1983, 64, 313-320.
• 19. Lee H.K., Cho Y.M., Kwak S.H., Lim S., Park KS., Shim E.B.: Mitochondrial disfunction and metabolit syndrome - looking for environmental factors. Biochim Biophys Acta 2010, 1800, 282-289.
• 20. Melnick R.L., Boorman G.A., Haseman J.K., Montali R.J., Huff J.: Urolithiasis and bladder carcinogenicity of melamine in rodents. Toxicol Appl Pharmacol 1984, 72, 292-303.
• 21. Mosmann T.: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65, 55-63.
• 22. Organisation for Economic Co-operationan and Development. The 2007 OECD List of High Production Volume Chemicals Series on Testing and Assessment No. 112. Available at: www.oecd.org/dataoecd/32/9/ 43947965.pdf (accessed 3 November 2009).
• 23. Pohjala L., Tammela P., Samanta S.K., Yli-Kauhaluoma J., Vuorela P.: Assessing the data quality in predictive toxicology using a panel of cell lines and cytotoxicity assays. Anal Biochem 2007, 362, 221-228.
• 24. Puschner B., Poppenga R.H., Lowenstine L.J., Filigenzi M.S., Pesavento P.A.: Assessment of melamine and cyanuric acid toxicity in cats. J Vet Diagn Invest 2007, 19, 616-624.
• 25. US FDA Issues Interim Safety and Risk Assessment of Melamine and its Analogues in Food for Humans. October 3, 2008. www.fda.gov
• 26. Weyermann J., Lohmann D., Zimmer A.: A practical note on the use of cytotoxicity assays. Int J Pharm 2005, 288, 369-376.
• 27. WHO. Toxicological and health aspects of melamine and cyanuric acid. Report of a WHO Expert Meeting in collaboration with FAO supported by Health Canada. Geneva, 2009.
• 28. Wiwanitkit V.: Melamine: problems in obstetrics. Arch Gynecol Obstet 2009, 280, 345-346.
• 29. Yang J.-J., Tian Y.-T., Yang Z., Zhang T.: Effect of melamine on potassium currents in rat hippocampal CAI neurons. Toxicol In Vitro 2010, 24, 397-403.